English Italiano Deutsch France

Welcome to Scapa

Scapa Group plc is a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets.  Scapa has a global footprint, with production sites in Asia, Europe and the US.

Our worldwide service and supply chain capabilities place us in an excellent position to partner with global customers.  We are focused on sustainable growth and innovation, improving the solutions for our customers by applying our knowledge and expertise in advanced material technology and process solutions.

We conduct our activities through two distinct and separate businesses: Healthcare and Industrial, each with its own focus and strategy.

Scapa Healthcare is a leading strategic outsource partner of choice in the Advanced Wound Care, Consumer Wellness, Medical Device Fixation and Drug Delivery markets. 
http://scapahealthcare.com/

Scapa Industrial operates across a diverse range of market segments throughout Europe, North America and Asia, via the two business models of Engineered Products and Commercial Products.
www.scapaindustrial.com

Find out more »

UK Modern Slavery Act
Toxic Reduction Plan 2011
Toxic Reduction Annual Report 2016

 

 

 

Current share price: 404.00p   +3.00p

News

Year End Trading Update-April 2018
Scapa Group plc (AIM: SCPA) is today providing an unaudited year end update for the twelve months ended 31 March 2018.   Click here

Acquisition of BioMed Laboratories LLC
Scapa Group plc (“Scapa”) (AIM: SCPA) is pleased to announce that it has acquired the share capital of BioMed Laboratories LLC (“BioMed”), based in Dallas, Texas. Click here

Directorate Changes-Jan 2018
Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, today announces the following directorate changes. Click here